MicroRNA-22 is a master regulator of bone morphogenetic protein-7/6 homeostasis in the kidney

Area of Science:

• Nephrology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are increasingly recognized for their role in kidney diseases.
• The specific regulatory functions of miRNAs in kidney fibrosis, particularly concerning key signaling pathways, are not fully understood.
• Bone morphogenetic proteins (BMPs), including BMP-7 and BMP-6, are critical regulators of kidney fibrosis.

Purpose of the Study:

• To investigate the regulatory role of miRNAs on BMP-7/6 signaling in the context of kidney fibrosis.
• To identify specific miRNAs that target BMP-7/6 and elucidate their function in renal fibrogenesis.

Main Methods:

• Utilized the unilateral ureteral obstruction (UUO) mouse model to study kidney fibrosis.
• Bioinformatic analysis to identify potential miRNAs targeting BMP-7/6.
• Examined miRNA and BMP-7/6 expression levels in wild-type and miR-22 null mice.
• Assessed renal fibrosis and BMP-7/6 downstream targets in primary renal fibroblasts.

Main Results:

• miR-22 was identified as a direct inhibitor of BMP-7/6.
• miR-22 null mice exhibited elevated BMP-7/6 expression and attenuated renal fibrosis in the UUO model.
• A feedback loop was discovered where BMP-7/6 induces miR-22 expression, and miR-22 inhibits BMP-7/6.
• BMP-responsive elements were identified in the miR-22 promoter region.

Conclusions:

• miR-22 plays a critical role in regulating kidney fibrosis by modulating the BMP-7/6 signaling pathway.
• The identified regulatory feedback circuit between miR-22 and BMP-7/6 is a key mechanism in renal fibrogenesis.
• Targeting miR-22 or the BMP signaling pathway presents a potential therapeutic strategy for kidney fibrosis.